drugset

drugset / Trial / NCT00277108

Lexapro in the Treatment of Patients With Postpartum Depression

NCT00277108 ↗

Completed 20 enrolled University of Rochester Forest Laboratories · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if Escitalopram (Lexapro) is effective in the treatment of postpartum depression.

Timeline

Start: 2004-02
Primary completion: 2007-04
Completion: 2007-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Escitalopram	Small molecule	20 mg	—

Indications